Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2025 results , with sales up 3% year on year to $10.86 billion.

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

Avalere Health, a 2025 MM+M Agency 100 honoree, named Rhiannon Meaden, PhD, as head of medical strategy and transformation.

Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.

The top financial leader at Thermo Fisher Scientific Inc. plans to retire from the company in 2026 after more than a decade ...

In the bustling realm of life sciences, Thermo Fisher Scientific shows formidable resilience and innovation. The company's Q2 2025 earnings reveal a revenue of $10.85 billion, marking a 3% ...